1. Briefings

• How the impacts of debt on biodiversity can be taken up in COP17 decisions
• Risk assessment and risk management of living modified organisms
• Briefing paper: Biodiversity Offsets and Credits lack “High Integrity” and will not bring significant funding to Global South Countries and Communities
• Accountability and transparency of DSI databases “to all Parties” are critical for the success of the CBD’s multilateral mechanism (October 2026)
• Why we must critically assess and regulate synthetic biology before experiments are unleashed on biodiversity (October 2026)
• CBD COP17 and the Future of Synthetic Biology Governance (October 2026)

2. Articles

• Cali Fund: Developing Countries Reject Unequal Incentives and Unlawful DSI Publication
  by Nithin Ramakrishnan (29 Oct 26)
• Report: The Elephants in the Room Driving Biodiversity Destruction
  (16 Oct 26)
• Moving Beyond the Implementation Gap at COP17
  by Mirna Inés Fernández (15 Oct 26)
• Synthetic biology at CBD COP17
  (09 Oct 26)

3. ECO articles

• Cali Fund Certificates: An unbalanced and ineffective incentive
  by Nithin Ramakrishnan (22 Oct 26)
• The continued need for precautionary, holistic risk assessment guidance materials to ensure against new threats and mitigate old harms
  by Eva Sirinathsinghji (21 Oct 26)
• Elephants in the Room
  by TWN (19 Oct 26)
• The Cali Fund: A bargain at developing countries’ expense?
  by Nithin Ramakrishnan (19 Oct 26)